The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Minireview: Secondary β-Cell Failure in Type 2 Diabetes—A Convergence of Glucotoxicity and Lipotoxicity
Abstract
Chronic hyperglycemia and hyperlipidemia can exert deleterious effects on beta-cell function, respectively referred to as glucotoxicity and lipotoxicity. Over time, both contribute to the progressive deterioration of glucose homeostasis characteristic of type 2 diabetes. The mechanisms of glucotoxicity involve several transcription factors and are, at least in part, mediated by generation of chronic oxidative stress. Lipotoxicity is probably mediated by accumulation of a cytosolic signal derived from the fatty acid esterification pathway. Our view that hyperglycemia is a prerequisite for lipotoxicity is supported by several recent studies performed in our laboratories. First, prolonged in vitro exposure of isolated islets to fatty acids decreases insulin gene expression in the presence of high glucose concentrations only, and glucose is rate-limiting for the incorporation of fatty acids into neutral lipids. Second, normalization of blood glucose in Zucker diabetic fatty rats prevents accumulation of triglycerides and impairment of insulin gene expression in islets, whereas normalization of plasma lipid levels is without effect. Third, high-fat feeding in Goto-Kakizaki rats significantly impairs glucose-induced insulin secretion in vitro, whereas a similar diet has no effect in normoglycemic animals. We propose that chronic hyperglycemia, independent of hyperlipidemia, is toxic for beta-cell function, whereas chronic hyperlipidemia is deleterious only in the context of concomitant hyperglycemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prior studies have linked loss of β-cell identity and dedifferentiation to β-cell dysfunction in models of insulin resistance and reduced islet mass [38, 40].”
In the citing paper
“Islet inflammatory stress increases islet miR-21 expression and is associated with the altered β-cell identity [38].”
Citations
Cites
Pick, A., Clark, J., Kubstrup, C., Levisetti, M., Pugh, W., Bonner-Weir, S., & Polonsky, K. S. (1998) · Diabetes · doi:10.2337/diabetes.47.3.358 · Cited by 551
Cited by
Sorted by citations
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
“Data from Poitout, Robertson, and colleagues (355, 386, 387) have indicated that -cell lipotoxicity is an amplifying effect that is manifested only in the context of concurrent hyperglycemia.”
BackgroundMitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Islet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.1 · Cited by 1,482
Ceriello, A., & Motz, E. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000122852.22604.78 · Cited by 1,378
The Role for Endoplasmic Reticulum Stress in Diabetes Mellitus
Eizirik, D. L., Cardozo, A. K., & Cnop, M. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0015 · Cited by 1,173
“The loss of -cell mass in type 2 diabetes may be due to chronic exposure to high glucose and free fatty acid (FFA) levels (gluco- and lipotoxicity) (5, 23, 24).”
BackgroundMolecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
“Similarly, exposure of islets to elevated levels of fatty acids does not impair GSIS unless the islets are cultured at or above a threshold concentration of glucose (usually ∼8 mM”
BackgroundOxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Tangvarasittichai, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.456 · Cited by 1,284
Glucolipotoxicity: fuel excess and β-cell dysfunction
Poitout, V., & Robertson, R. P. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0023 · Cited by 1,092
Self-citationRegulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Fu, Z., Gilbert, E. R., & Liu, D. (2012) · Current Diabetes Reviews · doi:10.2174/157339913804143225 · Cited by 925
Type 2 Diabetes-a Matter of ß-Cell Life and Death?
Rhodes, C. J. (2005) · Science · doi:10.1126/science.1104345 · Cited by 903
β-Cell Failure in Diabetes and Preservation by Clinical Treatment
WAJCHENBERG, B. L. (2007) · Endocrine Reviews · doi:10.1210/10.1210/er.2006-0038 · Cited by 722
“-Cell exhaustion, according to Robertson et al. (47), refers to a physical depletion of -cell insulin stores secondary to prolonged chronic stimulation with glucose or nonglucose secretagogues, so that insulin secretion is not possible, even if the -cell were to become resensitized to glucose.”
BackgroundInfluentialKolluru, G. K., Bir, S. C., & Kevil, C. G. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/918267 · Cited by 752
“ROS causes loss of insulin type 1 diabetes by destructing the β cells but it causes insulin resistance in type 2 diabetes by β cell dysfunction of [49, 55, 56].”
BackgroundGlucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity
Parton, L. E., Ye, C. P., Coppari, R., Enriori, P. J., Choi, B., Zhang, C.-Y., Xu, C., Vianna, C. R., Balthasar, N., Lee, C. E., et al. (2007) · Nature · doi:10.1038/nature06098 · Cited by 700
The mitochondrial uncoupling-protein homologues
Krauss, S., Zhang, C., & Lowell, B. B. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1592 · Cited by 670
“Such a proposition might seem to be in conflict with other studies that show that oxidative stress causes β-cell dysfunction, increased apoptosis and consequent loss of β-cell mass (see Ref”
ResultThe role of FoxO in the regulation of metabolism
Gross, D. N., van den Heuvel, A. P. J., & Birnbaum, M. J. (2008) · Oncogene · doi:10.1038/onc.2008.25 · Cited by 571
“Both glucotoxicity and lipotoxicity increase the level of reactive oxygen species in beta cells (Poitout and Robertson, 2002; Robertson et al., 2004).”
BackgroundRole of peroxisomes in ros/rns-metabolism: Implications for human disease
Fransen, M., Nordgren, M., Wang, B., & Apanasets, O. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.001 · Cited by 644
Protein tyrosine phosphatase 1B inhibitors for diabetes
Johnson, T., Ermolieff, J., & Jirousek, M. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd895 · Cited by 660
Lipid homeostasis, lipotoxicity and the metabolic syndrome
Unger, R. H., Clark, G. O., Scherer, P. E., & Orci, L. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.10.006 · Cited by 511
Saturated Fatty Acids Synergize with Elevated Glucose to Cause Pancreatic β-Cell Death
El-Assaad, W., Buteau, J., Peyot, M., Nolan, C. J., Roduit, R., Hardy, S., Joly, E. C., Dbaibo, G. S., Rosenberg, L. C., & Prentki, M. (2003) · Endocrinology · doi:10.1210/en.2003-0410 · Cited by 586
Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis
Kaneto, H., Katakami, N., Matsuhisa, M., & Matsuoka, T. (2010) · Mediators of Inflammation · doi:10.1155/2010/453892 · Cited by 590
Diabetes, oxidative stress and therapeutic strategies
Rochette, L., Zeller, M., Cottin, Y., & Vergely, C. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.05.017 · Cited by 543
De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose
Sanders, F., & Griffin, J. L. (2015) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12178 · Cited by 585
“It appears to be a component of the pathological basis of the hugely prevalent NAFLD, which may be an important and under acknowledged risk factor for T2DM.”
BackgroundInfluentialTXNIP regulates peripheral glucose metabolism in humans
Parikh, H., Carlsson, E., Chutkow, W. A., Johansson, L. E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P. C., Mazzini, M. J., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040158 · Cited by 495
“Hyperglycemia has long been known to exacerbate b-cell failure [52,53] and impaired skeletal muscle glucose uptake [54] via a process often termed glucose toxicity.”
BackgroundAcceleration of β Cell Aging Determines Diabetes and Senolysis Improves Disease Outcomes
Aguayo-Mazzucato, C., Andle, J., Lee, T. B., Midha, A., Talemal, L., Chipashvili, V., Hollister-Lock, J., van Deursen, J., Weir, G., & Bonner-Weir, S. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.006 · Cited by 469
Malonyl-CoA Signaling, Lipid Partitioning, and Glucolipotoxicity
Prentki, M., Joly, E. C., El-Assaad, W., & Roduit, R. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s405 · Cited by 428
Pathogenesis of Type 2 Diabetes Mellitus
Leahy, J. L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.003 · Cited by 469
Insulin Resistance, Obesity and Lipotoxicity
Yazıcı, D., & Sezer, H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_12 · Cited by 525
Current views on type 2 diabetes
Lin, Y., & Sun, Z. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0260 · Cited by 457
“Mechanisms include endoplasmic reticulum stress (Harding & Ron 2002), chronic hyperglycemia (Donath & Halban 2004), chronic hyperlipidemia (Poitout & Robertson 2002), oxidative stress (Kaneto et al. 2006), and inflammatory cytokines (Donath et al. 2003).”
BackgroundAMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
Ruderman, N., & Prentki, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1344 · Cited by 451
Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications
Donath, M. Y., & Halban, P. A. (2004) · Diabetologia · doi:10.1007/s00125-004-1336-4 · Cited by 430
Højberg, P. V., Vilsbøll, T., Rabøl, R., Knop, F. K., Bache, M., Krarup, T., Holst, J. J., & Madsbad, S. (2009) · Diabetologia · doi:10.1007/s00125-008-1195-5 · Cited by 414
“The progressive deterioration in beta cell function over time in patients with type 2 diabetes [16, 17], characterised by a beta cell secretory defect and decreased beta cell mass, results at least partly from prolonged exposure of beta cells to high glucose levels, referred to as glucotoxicity [1, 18–24].”
BackgroundStructure, mechanism and regulation of pyruvate carboxylase
Jitrapakdee, S., Maurice, M. S., Rayment, I., Cleland, W. W., Wallace, J. C., & Attwood, P. V. (2008) · Biochemical Journal · doi:10.1042/bj20080709 · Cited by 470
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction
Krauss, S., Zhang, C., Scorrano, L., Dalgaard, L. T., St‐Pierre, J., Grey, S. T., & Lowell, B. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19774 · Cited by 405
Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus
Akash, M. S. H., Rehman, K., & Chen, S. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24402 · Cited by 416
“In general, glucolipotoxicity is a common term used in combination for glucotoxicity and lipotoxicity as both are known to progress simultaneously [Poitout and Robertson, 2002].”
BackgroundPathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress
Yan, L. (2014) · Journal of Diabetes Research · doi:10.1155/2014/137919 · Cited by 425
Glucolipotoxicity of the pancreatic beta cell
Poitout, V., Amyot, J., Semache, M., Zarrouki, B., Hagman, D., & Fontés, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.08.006 · Cited by 382
Self-citationAnello, M., Lupi, R., Spampinato, D., Piro, S., Masini, M., Boggi, U., Del Prato, S., Rabuazzo, A. M., Purrello, F., & Marchetti, P. (2005) · Diabetologia · doi:10.1007/s00125-004-1627-9 · Cited by 385
Islet Inflammation in Type 2 Diabetes
Donath, M. Y., Schumann, D., Faulenbach, M. V., Ellingsgaard, H., Perren, A. A., & Ehses, J. A. (2008) · Diabetes Care · doi:10.2337/dc08-s243 · Cited by 351
Mitochondrial Networking Protects β-Cells From Nutrient-Induced Apoptosis
Molina, A. J. A., Wikstrom, J. D., Stiles, L., Las, G., Mohamed, H., Elorza, A., Walzer, G., Twig, G., Katz, S., Corkey, B. E., et al. (2009) · Diabetes · doi:10.2337/db07-1781 · Cited by 381
Mechanisms of β-Cell Death in Type 2 Diabetes
Donath, M. Y., Ehses, J. A., Maedler, K., Schumann, D. M., Ellingsgaard, H., Eppler, E., & Reinecke, M. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s108 · Cited by 444
Minn, A. H., Hafele, C., & Shalev, A. (2005) · Endocrinology · doi:10.1210/en.2004-1378 · Cited by 367
Insulin Signaling in the Central Nervous System
Porte, D., Baskin, D. G., & Schwartz, M. W. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1264 · Cited by 339
Emerging micro- and nanotechnology based synthetic approaches for insulin delivery
Mo, R., Jiang, T., Di, J., Tai, W., & Gu, Z. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60436e · Cited by 389
Erejuwa, O. O., Sulaiman, S. A., & Wahab, M. S. A. (2012) · Molecules · doi:10.3390/molecules17044400 · Cited by 384
“The role of oxidative stress is implicated in the decline of pancreatic function in diabetes mellitus [78,79].”
BackgroundThe Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
Bouché, C., Serdy, S., Kahn, C. R., & Goldfine, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0026 · Cited by 361
Glucagon-like peptide-1 prevents beta cell glucolipotoxicity
Joly, E. C., Prentki, M., Buteau, J., El-Assaad, W., Rhodes, C. J., & Rosenberg, L. (2004) · Diabetologia · doi:10.1007/s00125-004-1379-6 · Cited by 348
Obesity-related derangements in metabolic regulation
Muoio, D. M., & Newgard, C. B. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142512 · Cited by 345
Metabolic Syndrome Pathophysiology and Predisposing Factors
Bovolini, A., Garcia, J., Andrade, M. A., & Duarte, J. A. (2020) · International Journal of Sports Medicine · doi:10.1055/a-1263-0898 · Cited by 446
“The oxidative-rout inhibition leads to the accumulation of molecules derived from the acyl-CoA esterification such as ceramide, diglycerides, phospholipids, and also triglycerides in the β-cell cytoplasm [158, 159], triggering lipotoxic processes.”
BackgroundTeixeira‐Lemos, E., Nunes, S., Teixeira, F. J., & Reis, F. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-12 · Cited by 290
“Several studies showed that exposure of b cells to high levels of saturated fatty acids and lipoproteins undertake to their death, and this effect is accelerated by hyperglycaemia, demonstrating that lipotoxicity and glucotoxicity, in concert, determinate beta-cell failure [28-31].”
BackgroundGlycerolipid Metabolism and Signaling in Health and Disease
Prentki, M., & Madiraju, S. R. M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0007 · Cited by 331
“Several mechanisms have been proposed to explain -cell failure, including altered balance between insulin biosynthesis and secretion (also named -cell exhaustion) (311), oxidative stress (235, 312), ER stress (313), inflammation (314, 315), glucotoxicity (316), lipotoxicity (317, 318), and glucolipotoxicity proposed b…”
BackgroundType 2 diabetes as a protein misfolding disease
Mukherjee, A., Morales‐Scheihing, D., Butler, P. C., & Soto, C. A. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.04.005 · Cited by 349
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction
Krauss, S., Zhang, C.-Y., Scorrano, L., Dalgaard, L. T., St-Pierre, J., Grey, S. T., & Lowell, B. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319774 · Cited by 401
Yan, L., & Wu, J. (2015) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s82272 · Cited by 257
Involvement of Oxidative Stress in the Pathogenesis of Diabetes
Kaneto, H., Katakami, N., Kawamori, D., Miyatsuka, T., Sakamoto, K., Matsuoka, T., Matsuhisa, M., & Yamasaki, Y. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.1465 · Cited by 267
The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus
Rendell, M. (2004) · Drugs · doi:10.2165/00003495-200464120-00006 · Cited by 308
Johnson, P. J. (2002) · Veterinary Clinics of North America Equine Practice · doi:10.1016/s0749-0739(02)00006-8 · Cited by 264
Frank, N., Elliott, S. B., Brandt, L. E., & Keisler, D. H. (2006) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.228.9.1383 · Cited by 280
Ketosis-Prone Type 2 Diabetes in Patients of Sub-Saharan African Origin
Mauvais-Jarvis, F., Sobngwi, E., Porcher, R., Riveline, J.-P., Kevorkian, J.-P., Vaisse, C., Charpentier, G., Guillausseau, P.-J., Vexiau, P., & Gautier, J.-F. (2004) · Diabetes · doi:10.2337/diabetes.53.3.645 · Cited by 294
Conserved and Cooperative Assembly of Membrane-Bound α-Helical States of Islet Amyloid Polypeptide
Knight, J. D., Hebda, J. A., & Miranker, A. D. (2006) · Biochemistry · doi:10.1021/bi060579z · Cited by 310
“Furthermore, rodent ‚-cell function becomes impaired in early diabetes by an unknown mechanism ( 20 ).”
BackgroundROLE of MITOCHONDRIA in TOXIC OXIDATIVE STRESS
Fariss, M. W. (2005) · Molecular Interventions · doi:10.1124/mi.5.2.7 · Cited by 295
Antidiabetic actions of estrogen: Insight from human and genetic mouse models
Louet, J., May, C. L., & Mauvais‐Jarvis, F. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0030-9 · Cited by 286
Sone, H., & Kagawa, Y. (2005) · Diabetologia · doi:10.1007/s00125-004-1605-2 · Cited by 286
Thioredoxin-Interacting Protein
Chen, J., Saxena, G., Mungrue, I. N., Lusis, A. J., & Shalev, A. (2008) · Diabetes · doi:10.2337/db07-0715 · Cited by 346
The Association Between IGF-I and Insulin Resistance
Friedrich, N., Thuesen, B. H., Jørgensen, T., Juul, A., Spielhagen, C., Wallaschofksi, H., & Linneberg, A. R. (2012) · Diabetes Care · doi:10.2337/dc11-1833 · Cited by 283
Reducing insulin resistance with metformin: the evidence today
GIANNARELLI, R., Aragona, M., Coppelli, A., & Prato, S. D. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72785-2 · Cited by 272
Islet amyloid polypeptide: structure, function, and pathophysiology
Akter, R., Cao, P., Noor, H., Ridgway, Z., Tu, L.-H., Wang, H., Wong, A. G., Zhang, X., Abedini, A., Schmidt, A. M., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2798269 · Cited by 273
Rajpathak, S. N., Gunter, M. J., Wylie‐Rosett, J., Ho, G., Kaplan, R. C., Muzumdar, R. H., Rohan, T. E., & Strickler, H. D. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.919 · Cited by 263
Morioka, T., Asilmaz, E., Hu, J., Dishinger, J. F., Kurpad, A. J., Elias, C. F., Li, H., Elmquist, J. K., Kennedy, R. T., & Kulkarni, R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30910 · Cited by 249
Thioredoxin-interacting protein regulates insulin transcription through microRNA-204
Xu, G., Chen, J., Gu, J., & Shalev, A. (2013) · Nature Medicine · doi:10.1038/nm.3287 · Cited by 282
Regulation of the Insulin Gene by Glucose and Fatty Acids
Poitout, V., Hagman, D. K., Stein, R. W., Artner, I., Robertson, R. P., & Harmon, J. S. (2006) · Journal of Nutrition · doi:10.1093/jn/136.4.873 · Cited by 249
Self-citationER stress and SREBP-1 activation are implicated in β-cell glucolipotoxicity
Wang, H., Kouri, G., & Wollheim, C. B. (2005) · Journal of Cell Science · doi:10.1242/jcs.02513 · Cited by 268
“Hyperglycemia is proposed as the prerequisite for hyperlipidemia-induced -cell lipotoxicity (Bonner-Weir et al., 1983; Harmon et al., 2001; Poitout and Robertson, 2002; Roche et al., 1998; Weir, 1982; Weir et al., 2001).”
BackgroundPelengaris, S., & Khan, M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00294-7 · Cited by 230
Vitamin D deficiency and diabetes
Berridge, M. J. (2017) · Biochemical Journal · doi:10.1042/bcj20170042 · Cited by 279
El‐Moselhy, M. A., Taye, A., Sharkawi, S. S., El-Sisi, S. F., & Ahmed, A. F. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.02.004 · Cited by 185
Hagman, D., Hays, L., Parazzoli, S., & Poitout, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506000200 · Cited by 234
Self-citationElsner, M., Gehrmann, W., & Lenzen, S. (2011) · Diabetes · doi:10.2337/db09-1401 · Cited by 221
Vilsbøll, T., Brock, B., Perrild, H., Levin, K., Lervang, H. ‐., Kølendorf, K., Krarup, T., Schmitz, O., Zdravkovic, M., Le‐Thi, T., et al. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02333.x · Cited by 213
Pancreatic islet β‐cell and oxidative stress: The importance of glutathione peroxidase
Robertson, R. P., & Harmon, J. S. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.087 · Cited by 192
Self-citationInterleukin-1 (IL-1) family of cytokines: Role in Type 2 Diabetes
Banerjee, M., & Saxena, M. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.03.021 · Cited by 225
Mechanisms of islet amyloidosis toxicity in type 2 diabetes
Abedini, A., & Schmidt, A. M. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.017 · Cited by 206
“The decline in b-cell mass and function is attributed to several factors, including islet inflammation, glucolipotoxicity, accumulation of cholesterol and islet amyloid formation [40–43].”
BackgroundKaneto, H., Nakatani, Y., Kawamori, D., Miyatsuka, T., Matsuoka, T., Matsuhisa, M., & Yamasaki, Y. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.003 · Cited by 82
Kaneto, H., Nakatani, Y., Miyatsuka, T., Matsuoka, T., Matsuhisa, M., Hori, M., & Yamasaki, Y. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1009 · Cited by 189
Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes
Kaneto, H., Matsuoka, T.-A., Nakatani, Y., Kawamori, D., Miyatsuka, T., Matsuhisa, M., & Yamasaki, Y. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0640-x · Cited by 193
Rakatzi, I., Mueller, H., Ritzeler, O., Tennagels, N., & Eckel, J. (2004) · Diabetologia · doi:10.1007/s00125-003-1293-3 · Cited by 183
“Proinflammatory cytokines are considered to play a crucial role in the autoimmune-mediated beta-cell apoptosis leading to Type 1 diabetes development [2], whereas glucotoxicity and lipotoxicity represent the principal contributors involved in beta-cell failure in Type 2 diabetes [45].”
BackgroundKawamori, D., Kajimoto, Y., Kaneto, H., Umayahara, Y., Fujitani, Y., Miyatsuka, T., Watada, H., Leibiger, I. B., Yamasaki, Y., & Hori, M. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2896 · Cited by 207
Glucotoxicity and β-Cell Failure in Type 2 Diabetes Mellitus
Kaiser, Ν., Leibowitz, G., & Nesher, R. (2003) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2003.16.1.5 · Cited by 213
Oxidative stress and impaired insulin secretion in type 2 diabetes
ROBERTSON, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.09.002 · Cited by 168
Self-citationNagasumi, K., Esaki, R., Iwachidow, K., Yasuhara, Y., Ogi, K., Tanaka, H., Nakata, M., Yano, T., Shimakawa, K., Taketomi, S., et al. (2009) · Diabetes · doi:10.2337/db08-1233 · Cited by 188
Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic β ‐cells
Gehrmann, W., Elsner, M., & Lenzen, S. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01265.x · Cited by 176
The Genetic Basis of Type 2 Diabetes.
Das, S. K., & Elbein, S. C. (2006) · PubMed · doi:10.1901/jaba.2006.2-100 · Cited by 153
β-cell failure as a complication of diabetes
Chang-Chen, K. J., Mullur, R., & Bernal-Mizrachi, E. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9101-5 · Cited by 225
“Previous experiments have shown that long–chain acyl-CoA esters result in b-cell dysfunction [136].”
Minireview: Thioredoxin-Interacting Protein: Regulation and Function in the Pancreatic β-Cell
Shalev, A. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1095 · Cited by 180
Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes
Novials, A., Montané, J., & Cadavez, L. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s37649 · Cited by 164
Islet amyloid: From fundamental biophysics to mechanisms of cytotoxicity
Cao, P., Marek, P., Noor, H., Patsalo, V., Tu, L., Wang, H., Abedini, A., & Raleigh, D. P. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.046 · Cited by 178
Kornicka, K., Houston, J. M. I., & Marycz, K. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9809-x · Cited by 183
Healthy properties of proanthocyanidins
de la Iglesia, R., Milagro, F. I., Campión, J., Boqué, N., & Martínez, J. A. (2010) · BioFactors · doi:10.1002/biof.79 · Cited by 177
Uncoupling Protein 2 and Islet Function
Chan, C. B., Saleh, M. C., Koshkin, V., & Wheeler, M. B. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s136 · Cited by 161
Intrinsic Regulators of Pancreatic β-Cell Proliferation
Heit, J. J., Karnik, S. K., & Kim, S. K. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104425 · Cited by 165
Pancreatic β-cell growth and survival – a role in obesity-linked type 2 diabetes?
Lingohr, M. K., Buettner, R., & Rhodes, C. J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02377-8 · Cited by 168
Metadata
- Authors
- Poitout, V., & Robertson, R. P.
- Affiliations
- University of Washington (US)
- Corresponding author
- Poitout, Vincent
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2002-02
- Volume
- 143
- Issue
- 2
- Pages
- 339-342
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1971701221
- Cited by
- 743
- References
- 0
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 9 · 2023: 11 · 2022: 13 · 2021: 24 · 2020: 23 · 2019: 16 · 2018: 22 · 2017: 24 · 2016: 20 · 2015: 49 · 2014: 41 · 2013: 41 · 2012: 45
- FWCI
- 37.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R-01-DK-38325, R01 DK 58096)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- type 2 diabetes, beta-cell dysfunction, glucotoxicity, lipotoxicity, hyperglycemia, hyperlipidemia, oxidative stress, transcription factors, fatty acid esterification, insulin gene expression, glucose-stimulated insulin secretion, triglyceride accumulation, high-fat diet, islets
- MeSH terms
- Animals, Chronic Disease, Diabetes Mellitus, Type 2, Humans, Hyperglycemia, Hyperlipidemias, Islets of Langerhans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
